October 09, 2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

Got a startup idea? Curious about entrepreneurship? Then the GeneNovate program is the perfect place to start!

Objective

GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine. The program targets early-career scientists and physicians, such as advanced students, PhD candidates, and Postdocs, but it is also open to experienced researchers and medical professionals.

The GeneNovate program runs from December 2025 to June 2026 and includes a kick-off meeting in December, six theoretical input sessions (hybrid), six full-day workshops (onsite), team-based preparation and presentation of startup pitches and culminates in the Final Event in Munich

A key strength of the program lies in its collaborative approach, connecting participants across all GeneNovate locations in Germany. 

This comprehensive program is offered free of charge

Locations hosting the GeneNovate Workshops:

  • Berlin
  • Heidelberg
  • Munich
  • Region EAST (Dresden, Leipzig)
  • Region NORTH (Braunschweig, Göttingen, Hannover, …)
  • Region NRW 1 (Aachen, Bonn, Cologne, Düsseldorf, …)
  • Region NRW 2 (Bochum, Dortmund, Duisburg, Essen, …)
  • Region RHINE-MAIN (Mainz, …)
  • Region SOUTHWEST (Freiburg, Tübingen)

Apply now!

Registration for the remaining locations will open at a later date

Participate in Berlin: Submit your application here

Participate in Heidelberg: Submit your application here

Participate in Munich: Submit your application here

Participate in Region EAST (Dresden, Leipzig): Submit your application here

Participate in Region RHINE-MAIN (Mainz, …): Submit your application here


Program Framework

Kick-off Meeting | December 2025 

  • Participants will form teams and will be matched with mentors
  • Networking opportunity
  • Duration approx. 4 hours
  • Onsite participation at your selected location 

Theoretical Input Sessions | January 2026 to June 2026 

  • 6 theory sessions, held once per month, each lasting 4 hours
  • Onsite participation in Freiburg and Cologne, live stream for all other locations 

Workshops | January 2026 to June 2026 

  • Participants work in group exercises on the practical application of insights from the theoretical input sessions
  • Training from experts and experiences startups
  • 6 interactive sessions, held once per month, each lasting 6–8 hours
  • Onsite participation at your selected location 

Coaching Sessions with Mentors | January 2026 to June 2026 

  • Teams meet their mentor for about 1 hour after each workshop (in person or virtual) to prepare and rehearse the pitch for their startup
  • Approx. 8 hours in total 

Pre-selection of teams for the Final Event | June 2026 

  • Every team pitches their startup in front of a selection committee
  • Teams with the strongest pitches are selected to present at the Final Event in Munich 

Final Event 2026 in Munich | June 2026 

  • All participants, alumni, experts and mentors from all GeneNovate locations come together for networking, including the possibility to approach investors
  • Selected teams pitch their startup in front of investors
  • Panel discussions of experts and investors in the field
  • 1 full day in Munich

Our latest News

discover more
China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

The National Medical Products Administration (NMPA) in China has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic device in China. It is intended as a companion diagnostic to identify patients with MSI-high (MSI-H) solid tumors for treatment with KEYTRUDA® (pembrolizumab), the anti-PD-1 therapy from Merck & Co., Inc., […]

aimed analytics GmbH highlighted in deutsche-startups.de

aimed analytics GmbH highlighted in deutsche-startups.de

5 neue Startups: ONOX, aimed analytics, Recarbox, FORMIC, showroom.fm Es ist wieder soweit – neue Startups stehen in den Startlöchern! Hier sind einige spannende junge Unternehmen, die man kennen sollte. Heute werfen wir einen Blick auf diese Neugründungen: ONOX, aimed analytics, Recarbox, FORMIC und showroom.fm. deutsche-startups.de stellt heute erneut eine Auswahl junger Startups vor, die […]

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

Bridgetown, Barbados, January 27, 2026 – BioMed X, a leading innovation hub for pharma, today announced the launch of its first research project in partnership with the Government of Barbados and with support from the European Union’s PharmaNext Programme. The new global call for research proposals, entitled “AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados,” addresses one of the most pressing and underexplored […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp